How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly. News headlines Recursion Pharmaceuticals (RXRX) is navigating a challenging ...
Hosted on MSN
Recursion Pharma to reduce workforce by 20%
Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) traded higher in the premarket on Tuesday after the AI-driven biotech announced plans to reduce its workforce by approximately 20% as part of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results